Histone Deacetylase Inhibitor, Vorinostat, as an Enhancer of Gemcitabine Therapy for Resistant Pancreatic Tumors

被引：0
|
作者：
Green, L. J. [1 ]
Koshkina, N. [1 ]
Curley, S. A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [1] Histone deacetylase inhibitor, vorinostat, decreases transcription of survivin and is an enhancer of gemcitabine therapy for resistant pancreatic tumors
    Green, Leila J.
    Koshkina, Nadezhda V.
    Curley, Steven A.
    CANCER RESEARCH, 2012, 72
  • [2] Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor
    Marian Iwamoto
    Evan J. Friedman
    Punam Sandhu
    Nancy G. B. Agrawal
    Eric H. Rubin
    John A. Wagner
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 493 - 508
  • [3] Nonclinical Safety Assessment of the Histone Deacetylase Inhibitor Vorinostat
    Kerr, Janet S.
    Galloway, Sheila
    Lagrutta, Armando
    Armstrong, Michael
    Miller, Thomas
    Richon, Victoria M.
    Andrews, Paul A.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2010, 29 (01) : 3 - 19
  • [4] Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor
    Iwamoto, Marian
    Friedman, Evan J.
    Sandhu, Punam
    Agrawal, Nancy G. B.
    Rubin, Eric H.
    Wagner, John A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (03) : 493 - 508
  • [5] PRAVO PHASE I STUDY ON VORINOSTAT, A HISTONE DEACETYLASE INHIBITOR, IN PALLIATIVE RADIOTHERAPY FOR INTRAPELVIC TUMORS
    Ree, A.
    Flatmark, K.
    Folkvord, S.
    Johansen, M.
    Dueland, S.
    ANNALS OF ONCOLOGY, 2009, 20 : 97 - 97
  • [6] Mechanism for neurotropic action of vorinostat, a pan histone deacetylase inhibitor
    Shukla, Surabhi
    Shariat-Madar, Zia
    Walker, Larry A.
    Tekwani, Babu L.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2016, 77 : 11 - 20
  • [7] Vorinostat, a histone deacetylase inhibitor, as a potential novel treatment for psoriasis
    Samuelov, Liat
    Bochner, Ron
    Magal, Lee
    Malovitski, Kiril
    Sagiv, Nadav
    Nousbeck, Janna
    Keren, Aviad
    Fuchs-Telem, Dana
    Sarig, Ofer
    Gilhar, Amos
    Sprecher, Eli
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (04) : 567 - 576
  • [8] Histone deacetylase inhibitor MGCD0103 synergizes with gemcitabine in human pancreatic cells
    Sung, Victoria
    Richard, Normand
    Brady, Helen
    Maier, Armin
    Kelter, Gerhard
    Heise, Carla
    CANCER SCIENCE, 2011, 102 (06) : 1201 - 1207
  • [9] Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia
    Sachith Mettananda
    Nirmani Yasara
    Christopher A. Fisher
    Stephen Taylor
    Richard Gibbons
    Doug Higgs
    Scientific Reports, 9
  • [10] Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia
    Mettananda, Sachith
    Yasara, Nirmani
    Fisher, Christopher A.
    Taylor, Stephen
    Gibbons, Richard
    Higgs, Doug
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345